Kennedy Ferruggia, Associate Editor

The at-home test offers the availability to assess for all viruses using one tool.

Study findings could provide scientists more knowledge on why some populations face a higher risk of lung cancer compared to others.

Only 9% of older adults who reside in the United States had been vaccinated to protect themselves from RSV this fall and winter.

Study findings suggest that biomarkers could provide greater insight into different disease mechanisms and how treatments options could be more beneficial for certain patients.

The finding highlighted the importance of RSV risks among older adults, and aids pharmacists’ awareness when patients are hesitant to receive the RSV vaccine.

The findings suggest that the CAR T-cell membrane-coated PLGA nanoparticles reduced tumor size after 1 dose of treatment.

If vorasidenib receives full approval, it would be a first-in-class target therapy to treat individuals with IDH-mutant gliomas.

Researchers from Gilead remain confident for positive results as they continue the phase 3 EVOKE-03 study in 1L metastatic PD-L1-high NSCLC.

The approval of irinotecan liposome offers an improved first-line treatment option for individuals diagnosed with metastatic pancreatic adenocarcinoma.

The findings suggest that 6 months after vaccination with ARCT-154, individuals had a longer immune response.

A decrease in mortality and a lower risk of neonatal complications were reported among infants with vaccinated mothers.

A survey that analyzed treatment options and research for patients with NSCLC was conducted with medical oncologists.

The findings suggest that greater adherence to the WCRF/AICR Cancer Prevention Recommendations could greatly reduce the risk of all cancers combined, along with 14 others.

The burden of RSV in the older population is becoming highly recognized as studies have assessed higher-risk individuals in industrialized and developing countries.

The designation offers support in developing potential new medicines, treatment, and diagnosis to prevent rare conditions, like EoE.

The approval marks dupilumab as the first and only FDA-approved medicine to treat pediatric patients with eosinophilic esophagitis.

The schedule includes RSV vaccination, along with updated versions of the COVID-19 vaccine.

The products include Pilocarpine Hydrochloride Ophthalmic Solution 0.4%, Tenapanor, Zilucoplan, and Bimekizumab-bkzx.

The researchers found that the genomic material was extremely sensitive to the degradation.

Individuals that lived on a majority plant-based or vegetarian/vegan diet were 39% less likely to be infected with COVID-19.

The approval was based on the results of a phase 3 trial that found an improvement in progression-free survival among individuals treated with pembrolizumab.

RSV could interact with nerve cells, causing nerve damage and possible entry to the spinal cord.

The 10-year cumulative incidence rate was equally high between both cohorts of smoking and nonsmoking individuals.

Individuals with ischemic stroke that resided in areas with an indoor radon concentration greater than 4 pCi/L had an increased risk of developing clonal hematopoiesis of indeterminate potential.

The report allows management to provide guaranteed assessments throughout the screenings that could aid early detection, diagnosis, and lung cancer treatment.

If vaccination coverage was increased by 100%, outpatient care could be reduced by 81.2%, hospitalizations by 91.7%, and deaths by 91.3%.

The prospective observational study assessed a 2-year increasing lung cancer diagnosis risk, lung cancer characteristics, and the overall survival between LNP and LDCT screening.

The study highlights the ongoing need for health care providers to recommend respiratory illness vaccinations to increase protection among nursing home residents during the peak season of infection.

Families that reported a lower income before the pandemic were more likely to experience hardships if headed by an adult with COVID-19 illness.

Overtime, children can outgrow food allergies, like milk and eggs—however, children with private insurance are more likely to outgrow allergies than those with public insurance.